Search results for "area under the curve"

showing 10 items of 140 documents

GH responses to two consecutive bouts of neuromuscular electrical stimulation in healthy adults.

2008

BackgroundIt is well established that repeated GHRH administration or repeated voluntary exercise bouts are associated with a complete blunting of GH responsiveness when the administration of the second stimulus follows the first one after a 2-h interval.AimTo evaluate GH responses to neuromuscular electrical stimulation (NMES) in healthy adults.MethodsSix volunteers (mean age±s.d. 31.7±5.5 years) were studied before and after two consecutive bouts of NMES exercise (a series of 20 contractions at the maximum of individual tolerance, frequency: 75 Hz, pulse duration: 400 μs, on–off ratio: 6.25–20 s) administered at a 2-h interval.ResultsBaseline GH levels (mean: 0.3±0.2 ng/ml) significantly …

AdultFeedback PhysiologicalMalemedicine.medical_specialtyHydrocortisonebusiness.industryHuman Growth HormoneEndocrinology Diabetes and MetabolismArea under the curveStimulationGeneral MedicineStimulus (physiology)Growth Hormone-Releasing HormoneElectric StimulationQuadriceps MuscleEndocrinologyEndocrinologyInternal medicinemedicineHumansLactic AcidMuscle StrengthbusinessExerciseEuropean journal of endocrinology
researchProduct

Plasma Metabolites Associated with Frequent Red Wine Consumption: A Metabolomics Approach within the PREDIMED Study

2019

SCOPE: The relationship between red wine (RW) consumption and metabolism is poorly understood. We aimed to assess the systemic metabolomic profiles in relation to frequent RW consumption as well as the ability of a set of metabolites to discriminate RW consumers. METHODS AND RESULTS: Cross-sectional analysis of 1,157 participants. Subjects were divided as non-RW consumers versus RW consumers (> 1 glass/day RW (100 mL/day)). Plasma metabolomics analysis was performed using LC-MS. Associations between 386 identified metabolites and RW consumption were assessed using elastic net regression analysis taking into consideration baseline significant covariates. Ten-cross-validation (CV) was perform…

Male0301 basic medicinePopulationWineBiologySensitivity and SpecificityArticleEating03 medical and health sciencesMetabolomicsLinear regressionHumansMetabolomicsFood scienceeducationAgedWineeducation.field_of_study030109 nutrition & dieteticsReceiver operating characteristicSmokingArea under the curveRegression analysisMiddle AgedPredimedDietBloodCross-Sectional Studies030104 developmental biologyArea Under CurveFemaleFood ScienceBiotechnologyMolecular Nutrition & Food Research
researchProduct

Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension

1997

OBJECTIVE To analyze the relationship between insulinemia and urinary albumin excretion in a group of nonobese, young adult hypertensive patients, who had never been treated with antihypertensive drugs. PATIENTS AND METHODS Forty-nine patients who fulfilled the inclusion criteria were included. Twenty-four-hour ambulatory blood pressure monitorings, urinary albumin excretion (UAE) measurements, and an oral glucose-tolerance test measuring glucose and insulin, were performed, and left ventricular mass was measured by echocardiography. Hypertensive patients were classified as normoalbuminuric when their UAE was < 30 mg/24 h (40 patients; mean UAE 13.4 +/- 7.0 mg/24 h), and as microalbuminuric…

AdultBlood GlucoseMalemedicine.medical_specialtyAmbulatory blood pressurePhysiologymedicine.medical_treatmentUrologyBlood PressureEssential hypertensionRisk FactorsHyperinsulinismInternal medicineInternal MedicineHyperinsulinemiamedicineAlbuminuriaHumansInsulinProteinuriabusiness.industryInsulinArea under the curveGlucose Tolerance TestMiddle Agedmedicine.diseaseBlood pressureEndocrinologyCardiovascular DiseasesCase-Control StudiesHypertensionFemaleMicroalbuminuriamedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of Hypertension
researchProduct

D-dimer for risk stratification in haemodynamically stable patients with acute pulmonary embolism

2015

Patients with submassive pulmonary embolism (PE) have a higher short-term mortality than those with low-risk PE. Rapid identification of submassive PE is important for adequate treatment of non-massive PE. We aimed to investigate the utility of D-dimer for the prediction of submassive PE stadium in normotensive PE patients.Normotensive PE patients were classified into submassive or low-risk PE groups. In addition to the comparison of the groups, area under the curve (AUC) and D-dimer cut-off for the prediction of submassive PE stadium, multi-variate logistic regression for association between D-dimer values above this cut-off and submassive PE stadium were also calculated.The data of 129 no…

Malemedicine.medical_specialtyVentricular Dysfunction RightFibrin Fibrinogen Degradation ProductsTachycardiaInternal medicineHeart rateD-dimerHumansMedicineIn patientAgedRetrospective StudiesAged 80 and overbusiness.industryArea under the curveGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismLogistic ModelsBlood pressureHaemodynamically stableRisk stratificationCardiologyFemalePulmonary EmbolismbusinessAdvances in Medical Sciences
researchProduct

Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism

2014

The optimal N-terminal pro-brain natriuretic peptide (NT-proBNP) cut-off value for risk stratification of pulmonary embolism remains controversial. In this study we validated and compared different proposed NT-proBNP cut-off values in 688 normotensive patients with pulmonary embolism. During the first 30 days, 28 (4.1%) patients reached the primary outcome (pulmonary embolism-related death or complications) and 29 (4.2%) patients died. Receiver operating characteristic analysis yielded an area under the curve of 0.70 (0.60-0.80) for NT-proBNP. A cut-off value of 600 pg·mL(-1) was associated with the best prognostic performance (sensitivity 86% and specificity 50%) and the highest odds ratio…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyTime Factorsmedicine.drug_classVentricular Dysfunction Right030204 cardiovascular system & hematologyLogistic regressionRisk AssessmentSensitivity and Specificity03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineNatriuretic Peptide BrainOdds RatiomedicineNatriuretic peptideHumansProspective Studies030212 general & internal medicineProspective cohort studyAgedbusiness.industryArea under the curveReproducibility of ResultsOdds ratioMiddle AgedPrognosismedicine.diseasePeptide Fragments3. Good healthPulmonary embolismTreatment OutcomeROC CurveEchocardiographyPredictive value of testsMultivariate AnalysisCardiologyFemalePulmonary EmbolismRisk assessmentbusinessBiomarkersEuropean Respiratory Journal
researchProduct

Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

2016

Introduction Pharmacokinetic (PK) studies on recombinant FIX concentrate, Nonacog alpha, were conducted with different sampling time designs which gave rise to not complete and homogenous outcomes. In addition, patient's FIX genotype/PK relationship has never been investigated. Aim Investigate how different sampling times may affect PK parameters and try to find a FIX genotype/PK relationship. Patients and Methods A cohort pharmacokinetic, Nonacog Alpha single-dose, open-label, non-comparative study was conducted in eight Comprehensive Care Haemophilia Centres in Italy. Seventeen previously treated moderate or severe haemophilia B patients were enrolled. Factors IX:C one-stage clotting assa…

Malemedicine.medical_specialtyGenotypeMutation MissensePharmacokinetic030204 cardiovascular system & hematologyPharmacologyHaemophiliaGastroenterologyHemophilia BDrug Administration ScheduleCohort StudiesFactor IX03 medical and health sciences0302 clinical medicinePharmacokineticsDNA Recombinant proteinInternal medicineHaemophilia BGenotypemedicineHumansHaemophilia BGenetics (clinical)Volume of distributionClotting factorbusiness.industryCoagulantsArea under the curveGeneral MedicineHematologymedicine.diseaseRecombinant ProteinsItalyROC CurveCodon NonsenseArea Under Curvebusinesspharmacokinetics030215 immunologyBlood samplingHalf-Life
researchProduct

Alterations in the tear proteome of dry eye patients--a matter of the clinical phenotype.

2013

PURPOSE. Previous studies demonstrated alterations in the tear proteome of dry eye patients. The aim of the present study was to analyze tear protein patterns of dry eye patients considering different clinical phenotypes in order to examine their influence on tear film protein composition. METHODS. We applied a surface-enhanced laser desorption/ ionization-time-of-flight (SELDI-TOF)/matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF)/TOF mass spectrometry (MS)‐based strategy to detect/identify candidate biomarkers. Tear samples of 169 patients, enrolled in two independent studies, were analyzed. Patients were subdivided into healthy controls (CTRL: N ¼ 39), aqueous-defici…

AdultMalePathologymedicine.medical_specialtyProteomeTear proteinsDry Eye SyndromesGastroenterologyS100A8Internal medicinemedicineCalgranulinHumansClinical phenotypeEye ProteinsAgedbiologyReceiver operating characteristicArea under the curveMiddle AgedPhenotypeSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationTearsProteomebiology.proteinDry Eye SyndromesFemaleBiomarkersInvestigative ophthalmologyvisual science
researchProduct

Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma

2021

This study aimed to investigate the role of a panel of salivary cytokines as biomarkers for early detection oral squamous cell carcinoma (OSCC), comparing their levels among healthy individuals, patients with oral leukoplakia (OL), and malignant lesions. Cytokine profiling analysis performed in a minimally invasive sample was correlated with clinicopathological variables in our patient cohorts. Unstimulated saliva was obtained from subjects with OSCC at early (n = 33) and advanced (n = 33) disease, OL with homogeneous (n = 33) and proliferative verrucous (n = 33) clinical presentations, and healthy controls (n = 25). Salivary IL-1α, IL-6, IL-8, IP-10, MCP-1, TNF-α, HCC-1, and PF-4 levels we…

Salivamedicine.medical_specialtynon-invasive biomarkerslcsh:MedicineDiseaseGastroenterologyArticleoral leukoplakia03 medical and health sciences0302 clinical medicinesaliva testingSaliva testingInternal medicineMedicineBasal cellmedicine.diagnostic_testbusiness.industrylcsh:RNon invasive biomarkersArea under the curve030206 dentistryGeneral Medicineoral cancer3. Good healthOral leukoplakiastomatognathic diseasestranslational research030220 oncology & carcinogenesisImmunoassaybusinessJournal of Clinical Medicine
researchProduct

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity

2019

Background &amp; Aims: In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non-alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify differentially expressed mRNAs and non-coding RNAs in serum samples of biopsy-diagnosed mild and severe NAFLD patients with respect to controls and to each other. Methods: We first performed a whole transcriptome analysis through microarray (n = 12: four Control: CTRL; four mild NAFLD: NAS ≤ 4 F0; four severe NAFLD NAS ≥ 5 F3), followed by validation of selected transcripts through real-time PCRs in an independent internal cohort of 88 subjects (63 NAFLD, 25 CTRL) and in an external …

Liver CirrhosisMaleRNA UntranslatedMicroarrayBiopsyGastroenterologyliquid-biopsySeverity of Illness IndexTranscriptomeCohort Studies0302 clinical medicineFibrosisSettore BIO/13 - Biologia ApplicataNon-alcoholic Fatty Liver DiseaseMedicineSettore MED/12 - Gastroenterologiamedicine.diagnostic_testFatty liverArea under the curveNASHUntranslatedMiddle AgedLiver030220 oncology & carcinogenesisLiver biopsyDisease Progression030211 gastroenterology & hepatologyFemalefibrosiAdultmedicine.medical_specialty03 medical and health sciencesPredictive Value of TestsInternal medicineNAFLDliquid‐biopsyExtracellularHumansHepatologybusiness.industryGene Expression Profilingfibrosismedicine.diseaseRNAsMetabolic Liver DiseaseROC CurveRNASteatohepatitisbusinessBiomarkers
researchProduct

Blood pressure for outcome prediction and risk stratification in acute pulmonary embolism.

2015

Abstract Introduction Risk stratification of patients with acute pulmonary embolism (PE) is crucial in deciding appropriate therapy management. Blood pressure (BP) is rapidly available and a reliable parameter. We aimed to investigate BP for short-term outcome in acute PE. Materials and methods Data of 182 patients with acute PE were analyzed retrospectively. Logistic regression models were calculated to investigate associations between BP and in-hospital-death as well as myocardial necrosis. Moreover, receiver operating characteristic (ROC) curves and cutoff values for systolic and diastolic BPs predicting in-hospital death and myocardial necrosis were computed. Results A total of 182 pati…

AdultMalemedicine.medical_specialtyAdolescentDiastoleBlood PressureRisk AssessmentNecrosisYoung AdultInternal medicinemedicineHumansHospital MortalityAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testReceiver operating characteristicbusiness.industryVentilation/perfusion scanMyocardiumArea under the curveBlood Pressure DeterminationGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisConfidence intervalSurgeryPulmonary embolismBlood pressureLogistic ModelsROC CurveAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismThe American journal of emergency medicine
researchProduct